Introduction
After the second and third decades of life, testosterone levels decline gradually with advancing age, without a clear inflection point or andropause.
1
The age-related decline in testosterone levels has been associated with reductions in muscle mass, strength, physical function, and libido.
2-5
At this point, testosterone administration as a therapy has been largely used to improve muscle mass, physical function, mobility, and frailty. 1, [6] [7] [8] [9] [10] However, for several reasons, older men can be at a higher risk of experiencing adverse events during testosterone therapy when compared with young men. The plasma clearance of testosterone is lower in men aged 59 years than in young men (aged 19-35 years), 11 resulting in higher testosterone levels in older men at any testosterone dose. Some adverse events associated with testosterone administration are prostate-related effects, and cardiovascular-related events.
12-14 Furthermore, testosterone induces dose-dependent
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Abstract
Testosterone levels decline gradually with advancing age. At this point, testosterone administration as a therapy has been largely used to improve different outcomes. However, testosterone induces dose-dependent negative effects on the structure and function of the liver across age. Therefore, the present study aimed to carry out a systematic review of the effects of testosterone administration on the hepatic structure of adult and aged animals. We have searched the PubMed, Google Scholar, Science Direct, Scielo and Lilacs databases for animal experimental studies on the effects of testosterone administration on the hepatic structure across age. After applying the inclusion and exclusion criteria, we included two articles in a systematic review and meta-analysis (regarding adult/aged rats). We have shown through a systematic review with meta-analysis that testosterone may cause chronic hepatic congestion. However, the present review had a small number of studies, which was considered a limitation. At this point, we encourage the development of more studies to elucidate the cellular and molecular mechanisms involved in hepatic injuries, as well as the hepatic metabolism of exogenous testosterone across age.
negative effects on the structure and function of the liver across age.
15-17
The liver has its functions changed with advancing age, resulting in impaired regeneration and in a decrease in drug metabolism. 18, 19 Thus, testosterone administration can induce pathological conditions across age.
15,16
Currently, the clinical literature uses systematic reviews and meta-analyses to identify possible methodological differences in the studies, in the quality of the surveyed studies on a given topic, and in the most suitable intervention for a specific treatment.
8 Therefore, the present study aimed to carry out a systematic review of the effects of testosterone administration on the hepatic structure of adult and aged animals.
Materials and Methods
The present systematic review was developed based on the preferred reporting items for systematic reviews and metaanalyses (PRISMA) guideline, 20 
Inclusion and Exclusion Criteria
We have searched for animal experimental design studies on the administration of testosterone on the hepatic structure and the effect of aging on it. The inclusion criteria were articles with healthy young, adult or aged rodents, testosterone administration, and detailed data on hepatic morphology. We have excluded all of the papers that investigated testosterone administration on genetically modified animals, interventions such as surgery, or the use of any drug or nutritional supplement combined with testosterone administration. The strain of the rodents was not stated as an inclusion criterion.
Outcomes
The outcomes of interest were the area and the number of nuclei of hepatocytes, which indicate mitosis related to hepatic injury, as well as lobular (capillaries sinusoids, perisinusoidal spaces, and biliary ducts) and non-lobular (portal spaces, veins, and center-lobular branches of blood vessels) parenchyma components, which indicate changes in the hepatic blood flow.
Data Extraction and Analysis of Data Quality
We have extracted data about the strain of the rodents, as well as their age, gender, testosterone administration dosage and duration, and primary outcomes. Usually, clinical systematic review researchers apply a data quality analysis on the methodology of the analyzed papers through specific topic questionnaires. However, questionnaires for these purposes do not exist for animal studies. Therefore, we did not apply any data quality analysis in the present study. Data such as strain and/or age of the rodents were not used in the search strategy so as to not limit the amount of included studies.
Data Synthesis and Analysis
The systematic review data was organized in ►Tables 1 and 2.
15, 16 For the meta-analysis, RevMan 5.2 software (The Nordic Cochrane Centre, Copenhagen, Denmark) was used to calculate heterogeneity by the i-squared (I 2 ) and chisquared (χ 2 ) values. We have used the I 2 to assess the heterogeneity/homogeneity between the studies, using fixed effect models. We have also used the inverse variance method and 95% total confidence interval (95%CI). The present study is an analysis of published data; thus, it did not require the approval of an ethics committee.
Results

Selected Studies
After the initial intersection of mesh terms, entry terms, and/ or related keywords, the search identified 12,924 article titles. From this point, 4 evaluators (Nucci, Tanasov, de Souza and Gama) read the titles. Then, the abstracts were selected following the PRISMA 20 guideline. Of the total 12,924 articles, 52 were used for the initial abstract analysis. The abstracts should contain sufficient data on the parameters of the hepatic structure, on the animals studied, and on the treatments and/or interventions used in the studies. From these, five articles were included for full text analysis. After the inclusion and exclusion criteria were applied, two papers were included in the systematic review and meta-analysis. 15, 16 However, the small number of included papers should be considered a limitation.
Animal Strain, Age and Gender
In the selected articles, the strain of rodents used was Wistar rats (Rattus norvegicus). This strain is widely used in aging studies. Both studies presented data about the effects of testosterone administration on the hepatic structure of adult or aged animals. Both studies used male animals. 
Testosterone Administration, Duration and Dosage
Data Synthesis
Both studies 15, 16 used morphometrical and stereological methods to analyze the area and the number of nuclei of hepatocytes, as well as the lobular and non-lobular parenchyma components. All data are presented by the analysis of 2 studies, and 24 animals were included. Only adult and aged rodent data was considered. Age effect has not been evaluated at this point because the included articles did not present enough internal statistical data.
Meta-analysis
Number of Nuclei of Hepatocytes
The forest plot analysis demonstrated homogeneity (p ¼ 0.97; I 2 ¼ 0%) between the studies, and the testosterone 
Area of Nuclei of Hepatocytes
The forest plot analysis demonstrated homogeneity (p ¼ 0.56; I 2 ¼ 0%) between the studies, and the testosterone administration had a non-significant (p ¼ 0.52) decrease of 2.44 μm 2 in the hepatocyte nuclei area (95% CI: -9.90-5.01). ►Fig. 2 presents the data and the forest plot.
Lobular Parenchyma Components
The forest plot analysis demonstrated heterogeneity (p ¼ 0.04; I 2 ¼ 77%) between the studies, and the testosterone administration had a significant (p ¼ 0.0008) increase of 5.77% in the lobular parenchyma components (95% CI: 2.40-9.15). ►Fig. 3 presents the data and the forest plot.
Non-lobular Parenchyma Components
The forest plot analysis demonstrated homogeneity (p ¼ 0.98; I 2 ¼ 0%) between the studies, and the testosterone administration had a non-significant (p ¼ 0.69) decrease of 1.21% of in the non-lobular parenchyma components (95% CI: -7.12-4.69). ►Fig. 4 presents the data and the forest plot.
Discussion
Through a systematic review with meta-analysis, the present article analyzed the effects of testosterone administration on the hepatic structure of adult and aged animals. We have shown through a meta-analysis that testosterone may increase the mitotic capacity of the hepatocytes. The merging of both studies showed a decrease in the hepatocyte nuclei area, as well as an increase in the number of hepatocyte nuclei per field. This is consistent with studies that highlighted the role of testosterone as a contributing factor in mitosis due to its chemical and toxic aggression to the hepatic tissue.
15-17,22
However, our major finding was that testosterone changed the hepatic blood flow by increasing the lobular parenchyma components in both studies. 15, 16 Testosterone, at physiological concentrations, can selectively suppress the entry of calcium ions (Ca 2þ ) via L-type Ca 2þ channels, which indicates its vasodilatory actions. 23 Nonetheless, with testosterone administration, its vasodilatory actions could be more negative to the hepatic tissue in a dose-dependent fashion.
As the hepatic sinusoids dilate to accommodate the backflow of blood, the liver becomes tensely swollen. 24 Hence, this process may lead to blood stasis in the non-lobular parenchyma, leading to a hypoxic state. At this moment, a pathological process named hepatic congestion is characterized.
15,24,25
In addition, Simonetto et al 26 demonstrated through an experimental study in murine that chronic hepatic congestion leads to sinusoidal thrombosis and strain, which in turn promote hepatic fibrosis in the long-term. Additionally, a previous autopsy study of livers from patients with congestive heart failure demonstrated sinusoidal thrombi in the proximity of areas with fibrosis, and suggested a causative role of intrahepatic thrombosis in the incidence of fibrosis. 27 Furthermore, Nucci et al 15 showed that testosterone can injure the liver tissue, resulting in a sharp increase in fibrosis, which indicates chronic hepatic congestion in the short-term.
Conclusion
We have shown through a systematic review with metaanalysis that testosterone may cause chronic hepatic congestion in the short-term. However, the present review analyzed a small number of studies, which was considered a limitation. At this point, we encourage the development of more studies to elucidate the cellular and molecular mechanisms involved in hepatic injuries, as well as the hepatic metabolism of exogenous testosterone across age. Fig. 4 Forest plot presenting information about the effects of testosterone administration on the non-lobular parenchyma components in adult and aged rats (figure created using the RevMan 5.2 2017)
